Single Pass biopsy closure device. Credit: PRNewswire/ Single Pass, Inc.

Medical devices company Single Pass has entered an exclusive distribution agreement with Mermaid Medical Group to bring its advanced biopsy closure device to the US market.

The partnership aims to enhance patient care and improve procedural outcomes in biopsy closures.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

With its extensive network, Mermaid Medical Group will be the sole distributor of the Single Pass biopsy closure device in the US.

The company will also ensure widespread availability of the device to healthcare facilities in the country.

Single Pass CEO Bill Colone said: “Mermaid Medical Group’s reputation for excellence and their commitment to advancing patient care aligns perfectly with our mission. Together, we aim to revolutionise biopsy closure procedures and improve patient outcomes.”

The device will be more accessible to healthcare professionals by leveraging Mermaid Medical Group’s distribution capabilities to offer an advanced solution for biopsy closure procedures.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The Single Pass biopsy closure device is designed to offer healthcare professionals a safe and efficient method for closing biopsy sites.

The user-friendly design and advanced technology of the device are expected to reduce the risk of complications and promote faster patient recovery.

Mermaid Medical Group general manager Marcus Nielsen said: “We are excited to collaborate with Single Pass and introduce their groundbreaking biopsy closure device to the US market.

“This partnership reflects our dedication to providing healthcare professionals with innovative solutions that enhance patient care. We look forward to working closely with Single Pass to make this device widely accessible to medical facilities across the country.”

With a focus on advanced solutions development for biopsy closure procedures, the company aims to revolutionise the interventional medicine field.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact